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Beyond survivorship? A discursive analysis of how people with pancreatic cancer 
negotiate identity transitions in their health 
 
Abstract 
We explored how people negotiate, and respond to, identity transitions following a diagnosis 
of pancreatic cancer. Interviews with 19 people with pancreatic cancer were analysed using 
thematic discourse analysis. While discursively negotiating two transitions, “moving from 
healthy to ill” and “moving from active treatment to end-of-life care”, participants positioned 
themselves as “in control”, “optimistic” and managing their health and illness. In the absence 
of other discourses or “models” of life post-cancer, many people draw on the promise of 
survival. Moving away from “survivorship” may assist people with advanced cancer to make 
sense of their lives in a short timeframe.  
 
Introduction 
Pancreatic cancer is the fourth most common cause of cancer death globally (Güngör et al., 
2014). Most people are diagnosed with metastatic disease or locally advanced inoperable 
tumours (Güngör et al., 2014). For these people, treatment options are limited and many 
people will need palliative care to assist with pain and gastrointestinal symptoms (Gooden 
and White, 2013). While surgery is possible in 15-20% of patients, this does not offer a cure, 
and many people’s health and wellbeing will deteriorate (Güngör et al., 2014). Although 
physical and emotional adjustment to cancer is known to be challenging (Clarke et al., 2010; 
Zabernigg et al., 2012), little is known about how people make sense of their illness in 
relation to their identity and within the broader context of their lives.  
A cancer diagnosis can significantly affect a person’s identity which can, 
subsequently, shape their adjustment to cancer (Clarke et al., 2011), and how they can 
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construct a sense of meaning about their illness (Willig, 2009). In this paper, we took a 
discursive psychological perspective to consider how social meanings, interactions, and ways 
of speaking about cancer shape people’s understandings of cancer and consequently their 
identity and adjustment (Wetherell, 2007). Using a discursive perspective enables an 
understanding of how identity construction is ‘accomplished’ through language and within 
interpersonal and social contexts, by the availability of certain discourses (Peel et al., 2005; 
Willig, 2011). In the face of major life events, such as cancer, people tend to draw on 
‘dominant discourses’ – or socially available and acceptable ways of speaking about the 
experience – which can enable them to reconstruct their identity and make sense of their life. 
However, dominant discourses may restrict a person’s ability to understand and articulate 
their experience, and this may have negative consequences for their adjustment to cancer 
(Willig, 2009, 2011). Taking a discursive psychological perspective is therefore valuable, as 
it considers how people conceptualise and (re)construct their identity not only in relation to 
cancer but also regarding broader discourses surrounding this illness.  
In Western society, current understandings of health and illness are shaped by a move 
from state intervention to neoliberal policies that emphasise individual responsibility over 
health (Nettleton, 2013). Specifically, cancer is understood as an illness that individuals must 
work to avoid through self-surveillance, self-discipline, and modifying lifestyle behaviours 
(Bell, 2010; Willig, 2009). For people diagnosed with cancer, ‘working’ to survive is enacted 
through self-care practices such as diet, exercise, and the use of complementary and 
alternative medicine (Bell, 2010). These practices, along with talk of ‘survivorship’, 
constitute discourses of ‘individual responsibility’ and ‘survivorship’ and together can be 
understood as the prevailing model of cancer experience (Gibson et al., 2014; Kaiser, 2008; 
Willig, 2009). However, the discourses of individual responsibility and survivorship may 
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impose identities on people with cancer that restrict their ability to understand and adjust to 
their illness.  
Most studies exploring people’s post-cancer identities have been quantitative, been 
guided by the dominant survivorship model, and have emphasised a discrete set of identities 
in the literature (e.g., ‘survivor’, ‘patient’, ‘conqueror’) (Bellizzi and Blank, 2007; Chambers 
et al., 2012). Conversely, women with breast cancer have described disengagement from 
notions of ‘survivorship’ (Kaiser, 2008). A study with adolescents and young adults with 
cancer similarly found that most endorsed ‘someone who has cancer’ over the ‘survivor’ 
identity (Cho and Park, 2014). Notably, discourse analyst Carla Willig (2009) described her 
own personal struggle to gain meaning following a diagnosis of cancer in light of wider 
social meanings ascribed to cancer. Drawing on excerpts from her personal diary, she 
described having to frequently manage and defend her thoughts, feelings, and actions in the 
face of other people’s understandings of the illness. Nevertheless, she managed to construct a 
‘serviceable narrative’ that enabled her to make sense of the illness (Willig, 2009: 183).  
Drawing on her own experiences, Willig (2011: 2-3) went on to critique dominant 
discourses available to people with cancer, including the ‘cultural imperative to “think 
positively”’, and ‘cancer as a moral concern’. She argued that although discourses regarding 
cancer can be helpful, they can also limit or deny alternative meanings with which people can 
make sense of their illness. Talk of ‘survivorship’ and ‘personal responsibility’ may also be 
particularly restrictive, and potentially unhelpful, for people with advanced disease. However, 
few studies have considered the salience of this discourse for the identity construction of 
people with advanced cancer.  
In the context of advanced disease, the survivorship discourse – which emphasises 
personal control, responsibility, and optimism – is used to ‘empower’ patients to manage 
their pain (te Boveldt et al., 2014) and to have a ‘good death’. Kehl’s (2006: 277) review of 
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end-of-life literature identified several overarching themes that imply personal responsibility 
for a ‘good death’ including ‘being in control’, ‘relationships optimised’, and ‘leaving a 
legacy’. People with terminal cancer, their families, and doctors, are also expected to 
maintain ‘hope’ while being ‘realistic’ about the future (Broom et al., 2014; Campbell et al., 
2010). Although talk of ‘hope’ and ‘optimism’ may empower some, these discourses also 
valorise individual responsibility and may restrict expression of ‘negative’ emotions (e.g., 
anger) and opportunities for open and meaningful discussions about fears of death and dying. 
This raises questions about how people with advanced disease can form meaningful identities 
following diagnosis and how this illness affects their lives.  
Currently little is known about how identities are negotiated in relation to advanced 
disease, and how discourses shape people’s identities and, consequently, (dis)allow different 
paths of adjustment. In this paper, we provide a discursive analysis of how people negotiate 
and respond to identity transitions following a diagnosis of pancreatic cancer. We situate 
these transitions within the broader social and medical contexts of Western society, which 
emphasise individual responsibility for cancer survival, to provide insight into the 
multifaceted, contextual aspects of adjusting to a diagnosis of pancreatic cancer. 
Method 
The participants in this study were involved in a state-wide, case-control study of primary 
invasive pancreatic or ampullary cancer, conducted between January 2007 and June 2011. 
The methods of this study have been reported previously (Reference anonymised). A sub-
sample of participants were re-contacted and invited to be interviewed about their 
experiences following diagnosis. This research was approved by the Human Research Ethics 
Committee at the [anonymised]. 
Participants 
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Six women and 13 men, aged between 40 and 83 years (M = 67 years), were interviewed. 
Most participants had a heterosexual partner or were married, with two participants separated 
or divorced. Most had attended university (n = 13), four had completed high school, and two 
had fewer than 12 years’ education. Slightly less than half had had a surgical resection (n = 8) 
and 11 participants did not have a resection because they had locally advanced disease (n = 5) 
or metastases (n = 6) before surgery was attempted, meaning many faced a poor prognosis. 
Interviews 
[Author 2] conducted individual, semi-structured interviews until the topic had been 
investigated in such depth that additional interviews did not appear to produce new 
information. Of the 19 people interviewed, six were interviewed at home, and 14 were 
interviewed via Skype. In five interviews, the participant’s partner was present. This 
sometimes created varying dynamics; for example, partners would sometimes answer 
questions on behalf of the participant or dominate the interview in places. However, this did 
not create substantial differences in participants’ talk. The interviews began with a general 
question: ‘Can you tell your story of how you were diagnosed with pancreatic cancer?’ 
Subsequent questions explored interactions with health professionals, experiences of 
treatment, and people’s access to emotional, social, and physical support. The interviews 
varied in length (25 minutes to 1 hour and 10 minutes) and were guided by the participants to 
focus on the issues most important to them. 
Data Analysis 
The interviews were recorded, transcribed verbatim, and analysed using thematic discourse 
analysis (Clarke, 2005; Peel et al., 2005). As Willig (2011: 6) argued, ‘an understanding of 
the discursive context within which people experience a cancer diagnosis can enhance our 
understanding of the experience itself’. This analysis, therefore, involved searching for, and 
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identifying, repetitive patterns in the participants’ talk which formed ‘discursive themes’, 
when grouped together (Clarke, 2005: 7). Discursive themes are the application and 
manifestation of broader discourses within people’s day-to-day talk. Initial coding by [Author 
1 and Author 2] involved searching for recurring words, phrases, or clusters of meaning that 
participants drew on to construct their experiences of pancreatic cancer. Codes were then 
compared and refined by [Author 1 and Author 6] to form final discursive themes. These 
themes were analysed within a critical realist framework to consider how the broader socio-
cultural context shaped participants’ embodied experiences of having cancer (e.g., the 
physical and psychological manifestations of cancer) (Ussher, 2008). We examined both the 
physical reality of participants’ experiences of cancer (materiality) and how they understood 
and spoke about their illness (the discursive construction and articulation of having cancer). 
Finally, the analysis was discussed with the remaining authors to confirm and clarify 
interpretations.  
Analysis 
We identified two discursive themes relevant to this analysis, which captured the transitions 
participants experienced following a diagnosis of pancreatic cancer. The first theme, ‘moving 
from healthy to ill’, involved participants’ talk about their diagnosis and the links between 
their health and identity, including the rapid transition from being well to ‘ill’ and the 
associated physical and psychological symptoms and lifestyle modifications. The second 
theme, ‘moving from active treatment to end-of-life care’, illustrated another transition that 
participants faced when weighing up the decision to (dis)continue active treatment, thereby 
working to achieve reasonable quality of life and a ‘good death’.  
Moving from Healthy to Ill 
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The cancer diagnosis was constructed as destructive, erasing people’s ‘healthy’ identity and 
imposing a new identity – that of being a ‘sick’ patient with a life-threatening disease. Many 
participants described themselves as ‘healthy’ and ‘fit’ until their diagnosis and emphasised 
the ‘choices’ they had made to ensure a healthy life, thus drawing on neoliberal constructions 
of health as something that is promoted and achieved through healthy ‘choices’ and lifestyle 
behaviours (Nettleton, 2013). All of this was constructed as incompatible with their 
understanding of ‘illness’, which they described as something that should happen to people 
who had poor lifestyles (e.g., engaged in smoking or excessive alcohol consumption).  
Extract 1: 
[Husband] and I instinctively have always eaten a fairly healthy diet. We have lots of 
vegetables, we have lots of fruit. We steam rather than fry or deep-fry, I hardly ever deep-fry. 
I stir-fry, but I don’t deep-fry much. Don’t have fatty things much. Neither of us drinks much 
alcohol […] I never smoked. I wouldn’t say that I drank […] I did all of that healthy stuff, so 
good friends, good food, no excesses, so why do you get cancer? I don’t know. (Margareti, 
67, metastatic disease) 
Extract 2: 
I was not unwell, I was fit, I was healthy and that’s about it, and my first 55 years I’ve not 
spent a day in hospital other than to have my children and fix a broken ankle so it was a huge 
shock to us all. (Sarah, 55, metastatic disease) 
Extract 3: 
That was a hell of a shock because I don’t get ((pause)) I very rarely get ill, always been an 
active person you know. (Harry, 66, curative disease) 
Cancer diagnosis creates a disjuncture in a person’s ‘healthy’ narrative, raising questions 
about what ‘causes’ cancer. This shock was emphasised when participants were never 
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previously sick (Extracts 1-3), were asymptomatic (Extract 2), and were ‘healthy’ and 
‘active’ (Extract 3). For example, in extract 1, Margaret positioned herself as avoiding typical 
‘risk’ factors, such as smoking, drinking, and having a ‘bad’ diet. This description mirrors 
broader neoliberal health messages that portray cancer as preventable through modifiable 
behaviours and health as an individual’s responsibility (Broom et al., 2012; Nettleton, 2013). 
Many participants’ talk emphasised the challenges of post-hospital recovery, 
especially maintaining their mobility, and new diet and exercise restrictions, which 
contributed to a perceived loss of their identity.  
Extract 4: 
My biggest problem was food, especially at the beginning when I was on semi-liquids and 
what I could have. The dietician at the hospital was really good and I lost a lot of weight 
through this, and I still haven’t put it back because when you’ve lost these parts of your 
stomach, you eat small amounts and I always loved food. My taste buds altered a bit; I still 
find that some things I used to enjoy, I don’t. […] I’m keeping off highly spiced and fried 
foods. I like fried fish but I’m having grilled fish… (Jane, 75, curative disease) 
As Jane described above, a cancer diagnosis can trigger physical changes and alter a person’s 
identity (e.g., as someone who ‘always loved food’). Jane positioned herself as having to 
adjust her normal diet and preferences to cope with these changes. Jane’s talk of regulating 
her diet mirrored Margaret’s lengthy discussion of ‘stir frying’ instead of ‘deep frying’ food 
(Extract 1). This type of ‘accounting’ for one’s diet has been identified in people’s talk 
regarding other serious illnesses, such as Type II diabetes (Peel et al., 2005), and again 
illustrates the neoliberal focus on individuals’ responsibility for managing their health 
through behaviour and lifestyle modification post-cancer (Bell, 2010). As found in other 
work (Clarke et al., 2011), this talk also demonstrates the difficulties people can experience 
regarding previous pleasures or habits after cancer treatment. As these extracts show, cancer 
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can impose physical changes, which can affect people’s identity and sense of embodiment. 
Although the participants appeared to be somewhat compelled to ‘account’ for their diet and 
lifestyle, they could consequently position themselves as having agency. This could be 
helpful for some, in restoring a feeling of control after experiencing the senselessness of a 
cancer diagnosis. 
Renegotiating a new identity within the family context was another challenge for 
some participants. For example, Sarah described wanting to live her pre-cancer life, look after 
her family, and resist the effects of cancer by maintaining her independence:  
Extract 5: 
Many times we’ve had emotional upsets but as you know, my daughter felt not needed, she 
felt unneeded but my opinion was I did appreciate what she did or what she has done but I 
need to be able to maintain my independence because one day I’m not going to have that. 
Even to get in the car and be able to go somewhere, people felt they had to drive me, you 
know, it’s maintaining your independence and even my other two boys who are married with 
children, I said, ‘Look I need to help look after the children’. It makes me feel good to have 
that association with the kids and they didn’t want to over-tax me and still don’t, and I 
appreciate that but it is important to carry on life. (Sarah, 55, metastatic disease) 
Here, Sarah resisted the ‘sick identity’ by constructing a story where her priority and purpose 
was to be a caring, dedicated grandmother despite her family’s concerns. Sarah thus 
constructed herself as active, and as having some control, which could have been lost through 
a cancer diagnosis and the ‘patient’ identity (Willig, 2011). Sarah’s need for normality and 
independence for as long as possible also reflects other qualitative studies with people with 
cancer, which describe how many people wish to regain their original social roles (Clarke et 
al., 2011) or fear ‘being a burden’ on family, be it emotionally, physically, socially, or 
financially (Johnson et al., 2007).  
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Sarah also emphasised the difficulty of balancing her needs within the context of her 
caring family. It is important to consider the many ways (be it identity, sense of embodiment 
or control) that cancer can affect the person with cancer and the network of people supporting 
that person. Managing the psychological and relational aspects of advanced cancer requires 
negotiation by all involved, and needs to be supported, to avoid hindering people’s 
adjustment to incurable disease.  
Moving from Active Treatment to End-of-life Care 
The poor prognosis of pancreatic cancer offers little time for people to adjust to their 
diagnosis or prepare for decline in vitality and impending death. While some people decide to 
continue active treatment (i.e., chemotherapy), others transition into end-of-life care. The 
participants engaged in one of two strategies to manage their identities when faced with this 
decision: either positioning themselves as ‘being positive’ or as ‘being pragmatic’. Although 
these strategies result in different treatment decisions, both involve some degree of individual 
responsibility and are shaped by social expectations regarding how to cope with cancer and 
the prospect of death.  
Being positive 
Many participants drew on a discourse of optimism when speaking about their diagnosis and 
their treatment decision-making. Using this discourse, they described themselves as ‘tough’, 
keeping a ‘positive attitude’, and being able to cope with cancer and its treatment, thereby 
constructing cancer as something to be individually overcome. Participants also constructed 
this approach as potentially extending their lives, sometimes indefinitely (regardless of 
prognosis).  
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Extract 6: 
I am fully determined to beat this bloody thing, for how long I don’t know, but I’m going to 
give it a real good run. (Graham, 68, palliative locally advanced disease) 
Extract 7: 
[W]e saw this oncologist and got the bad news really. And that’s when… well I knew by then 
that I had cancer so that was bad; and I knew in the liver the outcome is not as good as if you 
have breast cancer or leukaemia or a few other things. So I asked the specialist, I said, 
‘Righto,’ and he had the charts on the desk, I looked like raisin toast. And he said, ‘Without 
treatment 2-4 months; with treatment 1-2 years. We can’t fix you’. Well I just said, ‘Look I’m 
not accepting that, that’s not good enough,’ and he said, ‘Well we can put you in a 
programme’ […] I said, ‘Well I’ve got nothing to lose, I’ve just been told I might have 4 
months, or I might have a year or two. What can I lose? So I’ll have it’. (Margaret, 67, 
metastatic disease) 
In extract 6, Graham resisted considering end-of-life care yet, by focusing on ‘beating’ 
cancer. Similarly, in extract 7, while Margaret understood her limited ‘outcome’, she 
constructed having ‘no treatment’ as unacceptable, favouring an experimental treatment, to 
have more time. The use of sports metaphors (‘real good run’) or constructing cancer as 
something to be ‘beaten’ mirrors socially-established ways of talking about cancer (Kaiser, 
2008; Willig, 2009, 2011) and highlights broader discourses of optimism and survivorship 
that circulate in Western society (Gibson et al., 2014).  
Participants also spoke of doctors who appeared to support their positive thinking, 
thereby highlighting the socially-endorsed quality of this approach:  
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Extract 8: 
Well I’ve always been a good healer. The surgeon said, ‘With your positive attitude, that will 
help you to the tune of about 20%’. [...] They were his words, not mine. (Harry, 66, curative 
disease) 
Extract 9: 
Interviewer: So what is the life expectancy that they’ve given you? 
Wife: They don’t. 
Kevin (61, curative disease): They won’t give you a life expectancy; all they will give you is 
a percentage. If you’re still alive in 5 years, they give you 20% to be alive in 5 years. Between 
1 in 5. There are people who have lived 15 years with it. 
Wife: Fifteen was the longest, roughly.  
Kevin: So you look on the positive side and all the doctors say, ‘No, you’ll be right. We’ve 
caught it nice and early; it hasn’t spread, you haven’t had bad symptoms’. 
In extract 8, Harry constructed his ‘positive attitude’ as being endorsed by his surgeon. Other 
participants also spoke of doctors’ encouragement of ‘positive thinking’, even when the 
prognosis was uncertain, as illustrated in extract 9. Kevin and his wife discussed the doctors’ 
response to their questions regarding his prognosis, which was marked by reference to 
percentages and positive talk. Kevin drew on the doctors’ positivity to emphasise ‘look[ing] 
on the positive side’ as a response to uncertainty. As shown above, discourses of optimism 
and positive thinking can be helpful for some people in coping with the uncertainty of cancer, 
by allowing them to position themselves in more secure ways (Gibson et al., 2015). 
Participants also discussed staying positive in relation to their partners, as illustrated 
in the next extract. 
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Extract 10: 
I think it’s up to the individual to help themselves, some people, we’ve heard give up. When 
they hear about the effects of chemotherapy and things like that, they don’t want to go 
through it. And they end up, they die. And there is no need for them to just give up, I don’t 
know why they do, I don’t understand that. Myself and my wife, we’d go through anything to 
stay together and just have more years together. (Steve, 65, curative disease) 
In extract 10, Steve drew on notions of individual responsibility regarding cancer survival 
and constructed people’s decisions to end active treatment as ‘giv[ing] up’. Steve contrasted 
this with his relationship with his wife and their determination to endure ‘anything’ to have 
more time together. In doing so, Steve situated his illness within his broader biographical 
narrative (e.g., as being in a relationship) to aid his decision-making. This talk of facing 
cancer together was identified across the participants who were married or in de facto 
relationships, again showing the relational aspect of dealing with cancer. Similarly, as Jane 
related, choosing to continue treatment can sometimes be made because of family. 
Extract 11: 
Interviewer: So has your experience been with the chemo, has it been… 
Jane (75, curative disease): They’re having trouble now getting the blood out. The lass did it 
good yesterday and there was not trouble but when I took the plaster... the plaster they put on 
when they take the needle out, I took that off this morning and the whole thing was raised and 
it was sore, so I’ve put cream on, and I haven’t had that before. One day, one lass kept poking 
about here trying to get it out and that took a month before that... if I push hard, I can still feel 
it. So that’s when... and then I thought oh what’s the point of doing it, because they tell me 
that it’s only one in three chemo works for. My children and my friends keep saying, ‘Well 
you could be the one that it works for, keep doing it’ […] I’ve kept at it. 
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In extract 11, Jane juxtaposed her discomfort and uncertainty about continuing treatment with 
the encouraging responses of her children and friends. By pointing to others’ hope and 
encouragement, Jane could explain why she continued chemotherapy, despite her discomfort 
and disillusionment. Taking a positive approach is therefore not always an individual choice, 
but can be one that is made for, or because of, others. 
Other qualitative studies with people with cancer suggest that optimism or ‘staying 
positive’ enables people with cancer and their families to maintain ‘hope’, which helps 
people to gain a sense of normality and focus on the future (O’Baugh et al., 2003; Reb, 
2007). Similarly, doctors sometimes delay conversations about palliative care if they perceive 
patients’ reticence to have such conversations (Broom et al., 2014).  
Being pragmatic 
Not all participants chose to focus on the positives or to assert control over cancer; instead, 
they focused on the seriousness, uncertainty, and materiality of the disease (e.g., the severe 
side-effects), and ‘worked’ towards a ‘good death’ (Kehl, 2006). Drawing on notions of the 
‘good death’, some participants emphasised the importance of quality of life and achieving 
meaning in their lives, often by spending time with friends and family. Several participants 
also discussed practical ways in which they coped with, or made sense of, their experience. 
For example, they spoke about trying to ‘make each day count’ with those around them: 
Extract 12: 
[I]t probably took a couple of months for us to say right well we need to move on and just 
make each day count. (Sarah, 55, metastatic disease) 
Extract 13: 
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[T]he main way we cope with this is we’re doing other projects like renovating and things 
like that. That’s the way to cope, because we’ve got six months and it’s better than sitting 
around thinking about how terrible it is, we just are doing things. It’s the best way to cope. 
(Wife of Steve, 65, curative disease) 
When participants positioned themselves in this way, they constructed themselves as 
accepting the seriousness of their cancer and as trying to make the most of their remaining 
time. Notably, participants of varying ages (55 – 83) positioned themselves as being 
pragmatic. However, most participants wanted to be sure that they had done all they could to 
ensure their survival before discontinuing treatment. For Garry, his palliative care physician 
played an important role in his decision-making:  
Extract 14: 
I know there is no cure, and it’s interesting seeing a palliative care physician which I do also; 
she says at some stage you’ve really got to pull the plug on treatment and I totally agree with 
her. And get on and enjoy the rest of your life while you can. If after two months I’m still in 
no pain and my CT scan is fine, and everything, I might go back on another course of chemo. 
That’s my plan. (Garry, 72, metastatic disease) 
The difficulties of decision-making were evident in Garry’s talk. While he acknowledged and 
valued his physician’s perspective, committing to ending treatment was difficult and was 
synonymous with death. For example, the phrase ‘pull the plug’ used by Garry is often used 
in the context of end-of-life care when turning off life support, and emphasises the ‘finality’ 
of the situation. His plan to have a progressive transition to end-of-life care perhaps 
minimised the feeling that he had made an abrupt decision about his life and positioned him 
as remaining hopeful and not giving up. Although there is evidence to suggest that health 
professionals prefer to have clear, clinical distinctions between patients in ‘active treatment’ 
and those in ‘palliative care’ (Schildmann et al., 2013), this extract highlights the importance 
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of health professionals being flexible and understanding the psychosocial complexity for 
patients with advanced disease.     
For many participants, achieving positive quality of life involved weighing up 
whether to continue or discontinue their treatment while considering relationships with 
others. Giving oneself permission to stop treatment often required gaining support from 
others, particularly relatives. 
Extract 15: 
Husband: I think the treatment that we have had so far has been good, we are prepared for 
whatever comes, we don’t know how chemotherapy is going to affect her at all. Quite often 
Claire is quite happy… if she has to die she’ll die, that’s all there is to it.  
Claire (83, palliative locally advanced disease): After all, I’m 83. And I think that’s a pretty 
good life. We’re quite prepared for that, aren’t we? 
Husband: See the thing is, if the treatment or chemotherapy is going to mean that she is 
going to be very sick and that sort of thing, and suffering all the time, is there any sense to 
keep going for a few months or so? For her quality of life; we don’t think it is that important. 
We’re getting to the stage where we are old enough that if we have to go, we have to go, 
that’s all there is to it.  
In extract 15, compared to younger participants, this couple constructed quality of life as 
more important than continuing treatment. They also constructed death as inevitable, as 
opposed to being something to be deferred. Both positioned themselves as being ‘prepared’ to 
face death as an outcome of cancer, and as congruent with their narrative trajectory and age 
(‘we are old enough’). This talk illustrates the acceptance of death that forms part of ‘dying 
well’ (Kehl, 2006). As other researchers have described, decision-making about end-of-life 
care often occurs within the family context and is influenced by family dynamics and 
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preferences (Broom and Kirby, 2013). In the case of this couple, being in agreement made it 
easier to take a pragmatic approach to death and, specifically, to have a ‘good death’.  
 While some participants positioned themselves as being pragmatic about their 
prognosis, one participant had difficulty with her shortened prognosis, given its delivery: 
Extract 16: 
He told me I had 3 months to live. Surely you can find a better way of breaking news to 
people than saying you’ve got 3 months. Surely there is a better way you can come around 
and say to somebody, this is not good, but to say you’ve got 3 months, that was pretty rugged 
when 5 days previously I was as fit as a Mallee bull. Never had a sick day in my life. (Debra, 
68, metastatic disease) 
Similar to other participants, Debra referred to her previous health and the shock of the 
diagnosis, but emphasised the doctor’s manner in delivering her prognosis. Throughout her 
interview, Debra repeatedly referenced this event, highlighting its significance, and the 
importance of a person’s social and relational context when receiving a diagnosis of incurable 
cancer. Debra’s experience also emphasises the disjuncture between talk of death in the 
context of the prevailing cancer ‘survivorship’ model. The relatively short survival time of 
this illness could make it difficult for people to accept their prognosis, especially when death 
is constructed as not being a ‘socially acceptable option’ (Willig, 2011: 4). 
Discussion 
Pancreatic cancer is often associated with rapid reductions in people’s wellbeing and life 
expectancy, posing challenges to their identities and adjustment. In this study, participants 
constructed the cancer diagnosis as incompatible with their identities as active and healthy. 
To ‘account’ for the illness, many reflected on their previous lifestyle and demonstrated their 
lifestyle modifications post-diagnosis. Participants also discussed how cancer challenged 
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their identities or their roles within their families, and how they negotiated these changes 
during and after treatment. This reclaiming of agency could be helpful for some, but it also 
reinforces the neoliberal approach to cancer and the ‘survivorship’ model, which emphasises 
individuals’ responsibility for recovery from cancer (Bell, 2010; Gibson et al., 2015).  
Pancreatic cancer is often incurable, but in the absence of other models of dealing 
with cancer, many participants drew on the promise of survival, adopting ‘empowered’ 
positions and constructing themselves as having some control over cancer. The participants in 
this study appeared to use this strategy to cope with the uncertainty of cancer, to justify 
continuing treatment, and to position themselves as determined, even in light of uncertainty 
and a poor prognosis. Further, participants’ decisions to continue treatment and to ‘think 
positively’ were embedded within their social or medical relationships. Although staying 
‘positive’ or continuing treatment may be empowering, this positioning may limit end-of-life 
care discussions with doctors and family, and disallow other ways of speaking about or 
understanding a terminal illness (Broom et al., 2014; Willig, 2009, 2011).  
Some participants adopted a ‘pragmatic’ approach to end-of-life care. They, therefore, 
discussed palliative care with their doctors and relatives. Participants’ responses were, 
nevertheless, varied; some participants constructed this as the last resort, while others 
accepted the inevitability of death (which appeared to be shaped by participants’ ages and 
broader biographical narratives). The participants’ talk of end-of-life care can be read in 
relation to wider notions about what constitutes a ‘good death’ (Kehl, 2006).  
The notion of ‘good death’ is, however, somewhat problematic. It has facilitated a less 
medicalised approach to dying, but it has, subsequently, led to the creation of other 
prescriptive, socially-endorsed ideas regarding how people should die ‘well’ (Hart et al., 
1998). As Hart and colleagues (1998: 72) commented, the ‘good death’ is ‘an ideology that 
constructs a socially approved form of dying and death with powerfully prescribed and 
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normalised behaviours and choices’. In this study, participants who took a pragmatic 
approach to death were the minority, and most focused on ‘being positive’ and assumed that 
this would prolong their survival. It is important to consider that survival cannot be 
controlled, and that a ‘good death’ may not be achievable for all. Further, the very notion of 
‘achievement’ – entwined with these concepts – demonstrates how the current approach to 
cancer, death and dying is infused with neoliberal values of individualism, self-determination, 
and control. It is, therefore, important to encourage alternative discourses to enable people to 
construct meaningful identities in the face of advanced cancer and death. If less emphasis is 
placed on talk of ‘survivorship’ and ‘fighting’ or ‘conquering’ cancer, space might open up 
for earlier discussions about death that avoid threatening a person’s identity and relational 
context. Moreover, people then might have greater leeway to construct their own ‘serviceable 
narrative’ of cancer (Willig, 2009), which could help them come to terms with their illness.  
The participants’ talk was undoubtedly shaped by the interview process and the 
broader context of Western society. However, the purpose of this analysis was to illustrate 
some of the ways that rapid transitions in health, caused by an advanced illness, can 
challenge people’s identities and require re-construction. Further, participants’ talk of 
adjusting to cancer was embedded within a broader relational and social context, thus 
illustrating the importance of considering the contextual nature of identity construction. 
Future research could extend this by examining identity construction, and the salience of 
‘survivorship’ discourse, in light of other advanced illnesses. 
Conclusion 
In this study, identity construction among people with pancreatic cancer was relevant to their 
adjustment. Participants drew on neoliberal discourses of individual responsibility, optimism 
and survivorship to construct their identities. They engaged in a complex, on-going 
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negotiation of their identities over the course of their illness, collaborating with family and 
doctors, thus demonstrating that identity construction is fluid and responsive to people’s 
social and relational contexts. Offering open and free discussion about the different ways in 
which people with cancer construct their life post-diagnosis could help people with advanced 
cancer, their family, and health professionals to move away from emphasising neoliberal 
discourses of individual responsibility and survivorship. This approach could help people to 
construct meaningful identities that go beyond a focus on survivorship, to cope with rapid 
changes to their health and their life expectancy.   
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